HIV Therapeutics Market estimated to grow at a CAGR of 1.4 % by 2021 May.2017 | Page 3

Global HIV Therapeutics Market 1. Introduction 1.1 Market Definition 1.2 Study Deliverables 1.3 Base Currency, Base Year and Forecast Periods 1.4 General Study Assumptions 2. Research Methodology 2.1 Introduction 2.2 Research Phases 2.2.1 Secondary Research 2.2.2 Primary Research 2.2.3 Econometric Modelling 2.2.4 Expert Validation 2.3 Analysis Design 2.4 Study Timeline 3. Overview 3.1 Executive Summary 3.2 Key Inferences 3.3 Epidemology 4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC) 4.1 Market Drivers 4.2 Market Restraints 4.3 Key Challenges 4.4 Current Opportunities in the Market 5. Market Segmentation 5.1 Drug Class 5.1.1 Introduction 5.1.2 integrase inhibitor 5.1.3 nucleoside/nucleotide reverse transcriptase inhibitor 5.1.4 non-nucleoside turn around transcriptase inhibitor 5.1.5 HIV-1 protease inhibitor 5.1.6 pharmacokinetic enhancer [phone] | www.marketdataforecast.com | [email protected]